Toggle light / dark theme

We Need to Prepare For Quantum Attacks Now, Top US Scientists Warn

The promise of quantum computing brings with it some mind-blowing potential, but it also carries a new set of risks, scientists are warning.

Specifically, the enormous power of the tech could be used to crack the best cyber security we currently have in place.

A new report on the “progress and prospects” of quantum computing put together by the National Academies of Sciences, Engineering, and Medicine (NASEM) in the US says that work should start now on putting together algorithms to beat the bad guys.

Rare Brain-Eating Amoeba Kills Woman Who Filled Her Neti Pot With Tap Water

A 68-year-old Seattle woman who died after contracting a rare brain-eating amoeba used regular tap water to rinse her sinuses, according to new research.

As noted in a new International Journal of Infectious Diseases case study, the infection was initially misdiagnosed as a brain tumor. During surgery to remove the suspected tumor, the lead neurosurgeon, Charles Cobbs from Seattle’s Swedish Medical Center, was taken aback by the extent of the brain damage. So he extracted a sample for further testing.

Human Stem Cell Trial Successful Against Age-Related Frailty

Today, we want to highlight results from human trials in which stem cell transplants have been shown to reduce age-related frailty.

Age-related frailty and stem cell transplants

Currently, there are no specific approved therapies to address age-related frailty, which can cause elderly people to suffer potentially fatal falls and injuries. There has been considerable interest in stem cell therapies to combat frailty in recent years, and the results we will discuss today are from one of the more advanced human clinical trials exploring mesenchymal stem cell (MSC) transplants [1].

A Heart Failure Patient Actually Coughed Up This Blood Clot Shaped Like a Lung Passage

Though it resembles a coral, root system, or some other kind of growth, the above photo actually depicts a six-inch-wide blood clot in the near-perfect form of the right bronchial tree of a human lung, the Atlantic reported on Thursday. Even more uncomfortable is the revelation that it was not removed by medical staff, but in fact coughed up by a patient who was suffering from heart failure.

The photo was released in late November as part of the New England Journal of Medicine’s Images in Clinical Medicine series. University of California at San Francisco doctors Gavitt A. Woodard and Georg M. Wieselthaler wrote that it came from their patient, a 36-year-old man who had long struggled with chronic heart failure. The patient reportedly had a medical history including “heart failure with an ejection fraction of 20%, bioprosthetic aortic-valve replacement for bicuspid aortic stenosis, endovascular stenting of an aortic aneurysm, and placement of a permanent pacemaker for complete heart block.” When the patient was admitted to the hospital’s intensive care unit, they hooked him up to a pump designed to help circulate blood throughout the body:

An Impella ventricular assist device was placed for management of acute heart failure, and a continuous heparin infusion was initiated for systemic anticoagulation. During the next week, the patient had episodes of small-volume hemoptysis, increasing respiratory distress, and increasing use of supplemental oxygen (up to 20 liters delivered through a high-flow nasal cannula). During an extreme bout of coughing, the patient spontaneously expectorated an intact cast of the right bronchial tree.

Major breakthrough in quest for cancer vaccine

The idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove exactly how such a vaccine would work.

Now, a team of researchers at the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal has demonstrated that a vaccine can work. Not only that, it could become an extremely effective, non-invasive and cost-effective -fighting tool.

The team’s work was published yesterday in Science Translational Medicine.

Washington Post: Breaking News, World, US, DC News & Analysis

Virginia Tech announced Thursday it will receive a record $50 million gift to support biomedical research, a landmark donation for the public university that will expand the influence of its academic health center in Roanoke.

The gift comes from the Horace G. Fralin Charitable Trust and from Heywood and Cynthia Fralin. It is twice as large as the previous record, a $25 million donation from Alice and Bill Goodwin for an engineering building that opened in 2014 on the university’s main campus in Blacksburg.

The new funding will help the university recruit and retain researchers, a spokesman said. A biomedical research institute will be named for the Fralin family and based within the Virginia Tech Carilion Academic Health Center.

Jan Gruber – Looking at synergistic effects in longevity therapies

And his team at Yale-NUS have recently completed a detailed set of studies looking at eleven of the most promising anti-aging single drugs, using nematode worms (C. elegans) as their model organism.

Drug synergy found to increase lifespan in worms

Even though testing the effects of single drugs on health and longevity in various organisms is challenging by itself, and testing multiple drugs and their synergistic effects can be a logistical and statistical nightmare, they found some surprising results, including up to a 96 percent increase in lifespan [1]. As they conclude in their new paper:

/* */